A2 Biotherapeutics Closes $80 Million Series C Financing to …

A2 Biotherapeutics Closes $80 Million Series C Financing To …

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics, established in 2018, is a fully integrated discovery, development and manufacturing company based in Agoura Hills, Calif. A2 Bio plans to direct the Series C …

yahoo.com

A2 Bio Highlights Progress Of Tmod

3 weeks from now

A2 Biotherapeutics Closes $80 Million Series C Financing to Advance Clinical Development of its Precision Cell Therapies Using its Proprietary Tmod TM Technology Platform. AGOURA …

a2bio.com

A2 Biotherapeutics Closes $80 Million Series C Financing To …

3 weeks from now

January 09, 2025 09:02 AM Eastern Standard Time. AGOURA HILLS, Calif.–(BUSINESS WIRE)–A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first …

intelligence360.news

A2 Biotherapeutics Closes $80 Million Series C Financing To

3 weeks from now

Jan 9, 2025  · AGOURA HILLS, Calif.--(BUSINESS WIRE)--A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to …

biospace.com

A2 Bio Closes $80 Million Series C Financing Round

3 weeks from now

Jan 9, 2025  · Agoura Hills-based A2 Biotherapeutics, a clinical-stage cell therapy company, on Jan. 9 announced the closing of its $80 million Series C financing round, supported by a …

pacbiztimes.com

A2 Biotherapeutics Secures $80M Series C To Advance Logic …

3 weeks from now

Jan 17, 2025  · A2 Biotherapeutics, Inc., a clinical-stage company specialising in logic-gated cell therapies, has announced the successful close of an $80 million Series C financing round. The …

pharmasource.global

A2 Biotherapeutics Completes $80M Series C - Vcnewsdaily.com

3 weeks from now

Jan 9, 2025  · Your Source for Venture Capital and Private Equity Financings. A2 Biotherapeutics Completes $80M Series C. Back to Home. 2025-01-09. Tweet. AGOURA HILLS, CA, A2 …

vcnewsdaily.com

A2 Biotherapeutics Closes $80 Million Series C | Citybiz

3 weeks from now

Jan 9, 2025  · AGOURA HILLS, Calif. — (BUSINESS WIRE) — A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to …

citybiz.co

A2 Bio Closes $80M Series C Capital Raise

3 weeks from now

Jan 17, 2025  · James Robinson, CEO of A2 Biotherapeutics. (courtesy photo) Established in 2018, Agoura Hills-based A2 Biotherapeutics is developing first-in-class logic-gated cell …

pacbiztimes.com

A2 Biotherapeutics: $80 Million (Series C) Raised For Advancing ...

3 weeks from now

A2 Biotherapeutics - a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to target tumor cells and protect normal cells selectively - announced the closing of …

pulse2.com

A2 Biotherapeutics Closes $80 Million Series C Financing To …

3 weeks from now

Jan 9, 2025  · AGOURA HILLS, Calif. – A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to selectively target tumor …

envzone.com

A2 Biotherapeutics Secures $80 Million In Series C Funding For ...

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics, Inc . successfully closes an $80 million Series C financing round, led by The Column Group and Samsara BioCapital, to advance its cell therapy …

venturecapital.com

A2 Bio Closes $80M Series C Capital Raise

3 weeks from now

James Robinson, CEO of A2 Biotherapeutics. (courtesy photo) Established in 2018, Agoura Hills-based A2 Biotherapeutics is developing first-in-class logic-g ... A2 Bio closes $80M Series C …

newsbreak.com

A2 Biotherapeutics Raises $80M Series C Funding - Finsmes.com

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics, an Agoura Hills, CA-based clinical-stage cell therapy company developing logic-gated cell therapies to selectively target tumor cells and protect normal cells, …

finsmes.com

Series C - A2 Biotherapeutics - 2025-01-09 - Crunchbase

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics raised $80000000 on 2025-01-09 in Series C. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. ...

crunchbase.com

A2 Biotherapeutics - Raised $280M Funding From 13 Investors

3 weeks from now

Jan 30, 2025  · How much funding did A2 Biotherapeutics raise in its latest funding round? A2 Biotherapeutics raised $80M in its latest funding round, which was Series C round held on Jan …

tracxn.com

A2 Biotherapeutics Closes $80 Million Series C Financing To …

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to selectively target tumor cells and protect normal cells, …

financialcontent.com

A2 Biotherapeutics 1/9/2025 Capital Raise - Gaebler.com

3 weeks from now

On 1/9/2025, A2 Biotherapeutics secured $80 million in Series C funding from Samsara BioCapital and The Column Group. On 1/9/2025, A2 Biotherapeutics secured $80 million in …

gaebler.com

Cell Therapy Startup A2 Biotherapeutics Nets $80M Series C

3 weeks from now

Jan 9, 2025  · Cell ther­a­py start­up A2 Bio­ther­a­peu­tics nets $80M Se­ries C. ... A2 Bio­ther­a­peu­tics has raised $80 mil­lion to run three ex­per­i­men­tal CAR-T pro­grams for sol­id ...

endpts.com